Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment

The failure to report the issue has not put patients at risk, the F.D.A. said, but the drugmaker could face criminal and civil penalties.
By KATIE THOMAS from NYT Health https://ift.tt/2M3PJn4
via IFTTT
Drugs (Pharmaceuticals), Genetics and Heredity, your-feed-healthcare
Source The New York Times
Làm đẹp Blog 247